Generex Biotechnology Corp Asset Turnover Ratio (GNBT), as of third quarter 2021, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Generex Biotechnology Corp  (GNBT)
 

Generex Biotechnology Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Generex Biotechnology's asset turnover ratio has remained unchanged compare to previous quarter at 0.07 in the third quarter (Apr 30 2021)

Within sector Generex Biotechnology Corp achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the Third Quarter 2021 compared to previous quarter at no. .

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GNBT Asset Turnover Ratio (Apr 30 2021)
III. Quarter		 (Jan 31 2021)
II. Quarter		 (Oct 31 2020)
I. Quarter		 (Jul 31 2020)
IV. Quarter		 (Apr 30 2020)
III. Quarter
Y / Y Asset Change -11.51 % -12.65 % -7.56 % -16.01 % -28.98 %
Y / Y Revenue Change -95.85 % - -87.75 % - -54.37 %
Asset Turnover Ratio (TTM) 0.07 - 0.09 0.1 0.01
GNBT's Total Ranking # # # # #
Seq. Asset Change 0.91 % -0.82 % 1.11 % -12.55 % -0.4 %
Seq. Revenue Change - - -96.92 % 476.28 % -41.84 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 




GNBT Company Profile • Back to GNBT Efficiency Comparisons • Compare GNBT Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Apr 30 2021, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Apr 30 2021 Assets at quarter ending Apr 30 2021
Vyant Bio Inc   0.18 $ 4.547  Millions$ 25.545  Millions
Precision Biosciences Inc  0.18 $ 33.636  Millions$ 191.338  Millions
Alnylam Pharmaceuticals Inc   0.17 $ 570.943  Millions$ 3,335.995  Millions
Cytomx Therapeutics Inc   0.17 $ 66.740  Millions$ 392.621  Millions
Aspira Women s Health inc   0.17 $ 4.927  Millions$ 29.065  Millions
Royalty Pharma Plc  0.17 $ 2,695.076  Millions$ 15,902.652  Millions
Pacific Biosciences Of California Inc   0.17 $ 92.292  Millions$ 545.209  Millions
Guardant Health Inc   0.17 $ 297.885  Millions$ 1,789.542  Millions
Beone Medicines Ltd   0.17 $ 862.687  Millions$ 5,222.860  Millions
Dariohealth Corp   0.16 $ 8.978  Millions$ 54.486  Millions
Transmedics Group Inc   0.16 $ 25.162  Millions$ 155.067  Millions
Xeris Biopharma Holdings Inc   0.16 $ 26.842  Millions$ 165.746  Millions
Ligand Pharmaceuticals Incorporated  0.16 $ 208.408  Millions$ 1,286.948  Millions
China Health Industries Holdings Inc   0.16 $ 8.093  Millions$ 51.653  Millions
Orgenesis Inc   0.16 $ 15.163  Millions$ 97.435  Millions
Nutriband Inc   0.15 $ 1.258  Millions$ 8.192  Millions
Rvl Pharmaceuticals Plc  0.15 $ 61.452  Millions$ 404.015  Millions
Arrowhead Pharmaceuticals Inc   0.15 $ 89.123  Millions$ 589.383  Millions
Aptevo Therapeutics Inc   0.15 $ 6.730  Millions$ 44.557  Millions
Sutro Biopharma Inc   0.15 $ 50.230  Millions$ 334.354  Millions
Morphic Holding inc   0.15 $ 42.616  Millions$ 283.881  Millions
Intelgenx Technologies Corp   0.15 $ 1.628  Millions$ 10.881  Millions
Urogen Pharma Ltd   0.15 $ 19.284  Millions$ 130.097  Millions
Biohaven Ltd   0.15 $ 106.299  Millions$ 724.101  Millions
Korro Bio Inc   0.15 $ 34.371  Millions$ 236.335  Millions
Global Cord Blood Corp  0.14 $ 176.995  Millions$ 1,225.471  Millions
Sangamo Therapeutics Inc   0.14 $ 131.396  Millions$ 918.504  Millions
Editas Medicine Inc   0.14 $ 91.508  Millions$ 651.383  Millions
Acceleron Pharma inc  0.14 $ 112.937  Millions$ 808.833  Millions
Invitae Corporation  0.14 $ 318.971  Millions$ 2,296.712  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.